ClearPoint Neuro (CLPT) vs OraSure Technologies (OSUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OraSure Technologies (OSUR) has outperformed ClearPoint Neuro (CLPT) over the past year, gaining 18.0% versus a loss of 59.6%. Over five years, CLPT leads with a -40.6% price change compared with -64.5% for OSUR. ClearPoint Neuro is the larger company by market cap ($320.0 million vs $261.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLPT | OSUR |
|---|---|---|
| Share price | $10.49 | $3.80 |
| Market cap | $319.99M | $261.74M |
| 1-day change | -1.59% | +1.74% |
| YTD return | -22.08% | +54.13% |
| 1-year return | -59.61% | +18.04% |
| 5-year return | -40.65% | -64.51% |
| EPS (TTM) | $-1.18 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.10 | $4.58 |
| 52-week low | $8.27 | $2.08 |
| Distance from 52-week high | -65.15% | -17.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +124.02% | +5.40% |
| Average volume | 637.17K | 480.26K |
| Shares outstanding | 30.50M | 68.97M |
| Employees | 160 | 500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OSUR has outperformed CLPT by 77.6 percentage points over the past year.
About ClearPoint Neuro
CLPT stock →ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
Health Care · Medical/Dental Instruments · 160 employees
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
CLPT vs OSUR FAQ
Which is bigger, ClearPoint Neuro or OraSure Technologies?
ClearPoint Neuro (CLPT) is larger, with a market capitalization of $319.99M compared with $261.74M for OraSure Technologies (OSUR).
Which stock has performed better over the past year, CLPT or OSUR?
OSUR returned +18.04% over the past 12 months, compared with -59.61% for CLPT (price return, excluding dividends). Past performance does not predict future results.
Are ClearPoint Neuro and OraSure Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.